These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper. Raman SV; Markl M; Patel AR; Bryant J; Allen BD; Plein S; Seiberlich N J Cardiovasc Magn Reson; 2022 Mar; 24(1):13. PubMed ID: 35232470 [TBL] [Abstract][Full Text] [Related]
29. The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients. Mavrogeni SI; Markousis-Mavrogenis G; Vartela V; Manolopoulou D; Abate E; Hamadanchi A; Rigopoulos AG; Kolovou G; Noutsias M Heart Fail Rev; 2020 Nov; 25(6):1007-1015. PubMed ID: 31784859 [TBL] [Abstract][Full Text] [Related]
30. Cine-cardiac magnetic resonance to distinguish between ischemic and non-ischemic cardiomyopathies: a machine learning approach. Cau R; Pisu F; Pintus A; Palmisano V; Montisci R; Suri JS; Salgado R; Saba L Eur Radiol; 2024 Sep; 34(9):5691-5704. PubMed ID: 38451322 [TBL] [Abstract][Full Text] [Related]
31. Deactivation vs. asynchronous pacing - prospective evaluation of a protocol for rhythm management in patients with magnetic resonance conditional pacemakers undergoing adenosine stress cardiovascular magnetic resonance imaging. Klein-Wiele O; Garmer M; Barbone G; Urbien R; Busch M; Kara K; Schäfer H; Schulte-Hermes M; Hailer B; Grönemeyer D BMC Cardiovasc Disord; 2017 Jun; 17(1):142. PubMed ID: 28577544 [TBL] [Abstract][Full Text] [Related]
32. Additive value of magnetic resonance coronary angiography in a comprehensive cardiac magnetic resonance stress-rest protocol for detection of functionally significant coronary artery disease: a pilot study. Bettencourt N; Ferreira N; Chiribiri A; Schuster A; Sampaio F; Santos L; Melica B; Rodrigues A; Braga P; Teixeira M; Leite-Moreira A; Silva-Cardoso J; Portugal P; Gama V; Nagel E Circ Cardiovasc Imaging; 2013 Sep; 6(5):730-8. PubMed ID: 23833284 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy. Li Y; Liu X; Yang F; Wang J; Xu Y; Fang T; Pu L; Zhou X; Han Y; Chen Y Eur Radiol; 2021 Jul; 31(7):4557-4567. PubMed ID: 33449190 [TBL] [Abstract][Full Text] [Related]
34. Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies. Yang EY; Shah DJ Methodist Debakey Cardiovasc J; 2020; 16(2):97-105. PubMed ID: 32670469 [TBL] [Abstract][Full Text] [Related]
35. Clinical application of CMR in cardiomyopathies: evolving concepts and techniques : A position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology. Merlo M; Gagno G; Baritussio A; Bauce B; Biagini E; Canepa M; Cipriani A; Castelletti S; Dellegrottaglie S; Guaricci AI; Imazio M; Limongelli G; Musumeci MB; Parisi V; Pica S; Pontone G; Todiere G; Torlasco C; Basso C; Sinagra G; Filardi PP; Indolfi C; Autore C; Barison A Heart Fail Rev; 2023 Jan; 28(1):77-95. PubMed ID: 35536402 [TBL] [Abstract][Full Text] [Related]
36. Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review. Pan J; Ng SM; Neubauer S; Rider OJ Eur Heart J Cardiovasc Imaging; 2023 Sep; 24(10):1302-1317. PubMed ID: 37267310 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study. Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349 [TBL] [Abstract][Full Text] [Related]
38. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy. Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014 [TBL] [Abstract][Full Text] [Related]
39. Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle. Porcari A; De Luca A; Grigoratos C; Biondi F; Faganello G; Vitrella G; Nucifora G; Aquaro GD; Merlo M; Sinagra G Heart Fail Rev; 2022 Jan; 27(1):49-69. PubMed ID: 32564329 [TBL] [Abstract][Full Text] [Related]
40. CAD detection in patients with intermediate-high pre-test probability: low-dose CT delayed enhancement detects ischemic myocardial scar with moderate accuracy but does not improve performance of a stress-rest CT perfusion protocol. Bettencourt N; Ferreira ND; Leite D; Carvalho M; Ferreira WDS; Schuster A; Chiribiri A; Leite-Moreira A; Silva-Cardoso J; Nagel E; Gama V JACC Cardiovasc Imaging; 2013 Oct; 6(10):1062-1071. PubMed ID: 24011773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]